Lista de obras - Elda Tagliabue - Dominio Público Uruguay

"Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.

artículo científico publicado en 2014

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

artículo científico publicado en 2014

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

artículo científico publicado en 2017

Activity and resistance of trastuzumab according to different clinical settings.

artículo científico publicado en 2011

Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane

artículo científico publicado en 1993

Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency

artículo científico publicado en 1993

Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities.

artículo científico publicado en 2017

Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu

artículo científico publicado en 2008

Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN

artículo científico publicado en 2010

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.

artículo científico

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).

artículo científico publicado en 2013

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

artículo científico publicado en 2008

Breast cancer and microRNAs: therapeutic impact.

artículo científico

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

artículo científico publicado en 2016

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

artículo científico publicado en 2017

Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site

artículo científico publicado en 1991

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

artículo científico publicado en 1987

Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression

artículo científico publicado en 1992

Co-regulation and Physical Association of the 67-kDa Monomeric Laminin Receptor and the α6β4 Integrin

scientific article published on 01 January 1997

Combined targeting of EGFR and HER2 against prostate cancer stem cells

artículo científico publicado en 2020

Correspondence

scientific article published on 01 November 1998

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.

artículo científico publicado en 2016

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation

artículo científico publicado en 2019

Diadenosines as FHIT-ness instructors

artículo científico publicado en 2006

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

artículo científico publicado en 2018

Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.

artículo científico publicado en 2014

ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics

artículo científico publicado en 2018

EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.

artículo científico publicado en 2013

ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab

scientific article published on 20 February 2020

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

scientific article published on 27 November 2018

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

scientific article published on 13 August 2013

Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2

artículo científico publicado en 2007

Exploiting poly(I:C) to induce cancer cell apoptosis.

artículo científico publicado en 2017

Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells

artículo científico publicado en 2016

Expression of Bone Sialoprotein in Human Lung Cancer

scientific article published on 01 September 1997

Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death

artículo científico publicado en 2019

Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.

artículo científico publicado en 2010

Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

artículo científico publicado en 2020

Extracellular matrix proteins as diagnostic markers of breast carcinoma

artículo científico publicado en 2018

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

artículo científico publicado en 2008

FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells

artículo científico publicado en 2006

FOXP3 expression and overall survival in breast cancer.

artículo científico publicado en 2009

FOXP3 expression in tumor cells and implications for cancer progression.

artículo científico

Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells.

artículo científico publicado en 2015

Folate in head and neck squamous cell cancer chemoprevention: purposely left out?

artículo científico publicado en 2008

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

artículo científico publicado en 2005

HER2 as a target for breast cancer therapy.

artículo científico publicado en 2010

HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

artículo científico publicado en 2018

Heregulin β1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein

artículo científico publicado en 1998

Human Renal Antigen Defined by a Murine Monoclonal Antibody2

artículo científico publicado en 1984

Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model

article

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

artículo científico publicado en 2013

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

artículo científico publicado en 2011

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation

artículo científico publicado en 2013

Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands

artículo científico publicado en 2012

Infiltrating mast cell-mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype

scientific article published on 16 March 2020

Influence of Antibiotic Treatment on Breast Carcinoma Development in Proto-neu Transgenic Mice

article

Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/Neu transgenic mice

artículo científico publicado en 2013

Influence of lignans depletion on murine mammary gland morphology.

artículo científico publicado en 2010

Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness

scientific article published on 28 November 2020

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

artículo científico publicado en 2018

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

artículo científico

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

artículo científico publicado en 2018

Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness

scientific article published on 18 April 2006

Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases

artículo científico publicado en 2019

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.

artículo científico publicado en 2013

Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties

artículo científico publicado en 2008

Mexican <i>Ganoderma Lucidum</i> Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet

artículo científico publicado en 2020

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

artículo científico publicado en 2018

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

scientific article published on 12 August 2020

MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.

artículo científico publicado en 2018

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

artículo científico publicado en 2008

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

artículo científico publicado en 2012

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases

artículo científico publicado en 2018

Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines

artículo científico publicado en 2010

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.

artículo científico publicado en 2015

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress

artículo científico publicado en 2013

Nerve Growth Factor Cooperates with p185HER2in Activating Growth of Human Breast Carcinoma Cells

scientific article published on 01 February 2000

New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors.

artículo científico publicado en 2004

New insights into the role of extracellular matrix during tumor onset and progression.

artículo científico publicado en 2002

Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer.

artículo científico publicado en 2012

PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

artículo científico publicado en 2014

PET Prediction of Response to Trastuzumab in ErbB2-Positive Human Xenograft Model

scientific article published on 23 August 2012

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

artículo científico publicado en 2016

Peptide G, Containing the Binding Site of the 67-kDa Laminin Receptor, Increases and Stabilizes Laminin Binding to Cancer Cells

artículo científico publicado en 1996

Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2

artículo científico publicado en 2004

Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.

artículo científico publicado en 2014

Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment

artículo científico publicado en 2015

Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

artículo científico publicado en 2012

Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.

artículo científico publicado en 2017

Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge

artículo científico publicado en 2016

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients

article

Prognostic role of tumor size in T1 HER2-positive breast cancers treated with adjuvant trastuzumab

artículo científico publicado en 2014

Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas.

artículo científico

Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas.

artículo científico

Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification

artículo científico publicado en 2007

Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays.

artículo científico publicado en 2017

Radiation effects on development of HER2-positive breast carcinomas

artículo científico publicado en 2007

Regulation of breast cancer response to chemotherapy by fibulin-1.

artículo científico publicado en 2007

Relationship between p53 and p27 expression following HER2 signaling

artículo científico publicado en 2007

Relevance of Antibody Valency in EGF Receptor Modulation

scientific article published on 01 May 1994

Replacement of Fhit in cancer cells suppresses tumorigenicity

artículo científico publicado en 1997

Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor

artículo científico publicado en 2016

Ricin A Chain Conjugated With Monoclonal Antibodies Selectively Killing Human Carcinoma Cells In Vitro2

artículo científico publicado en 1985

Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients.

artículo científico publicado en 2011

Role of HER2 in wound-induced breast carcinoma proliferation.

artículo científico publicado en 2003

Role of HER2/neu in tumor progression and therapy

artículo científico publicado en 2004

Role of exon-16-deleted HER2 in breast carcinomas

artículo científico publicado en 2006

Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study

artículo científico publicado en 2007

Secondary electrospray ionization-mass spectrometry and a novel statistical bioinformatic approach identifies a cancer-related profile in exhaled breath of breast cancer patients: a pilot study

artículo científico publicado en 2015

Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility

artículo científico publicado en 2010

Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis.

artículo científico publicado en 2014

Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model

artículo científico publicado en 2012

TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer

artículo científico publicado en 2020

TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.

artículo científico publicado en 2011

Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.

artículo científico publicado en 2015

The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study

scientific article published on 05 July 2019

The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.

artículo científico publicado en 2005

The HER2 World: Better Treatment Selection for Better Outcome

artículo científico publicado en 2011

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.

artículo científico publicado en 2018

The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?

scientific article published on 28 June 2019

The early relapse of premenopausal patients after surgery for node-positive breast carcinoma

artículo científico publicado en 2001

The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

artículo científico publicado en 2011

The landscape of d16HER2 splice variant expression across HER2-positive cancers

artículo científico publicado en 2019

The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy

scientific article published on 23 January 2020

Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients

scientific article published on 03 October 2019

Triple-negative breast cancer: present challenges and new perspectives

artículo científico publicado en 2010

Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors

artículo científico publicado en 2019

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers

artículo científico publicado en 2010

Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression

artículo científico publicado en 2015

Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab

artículo científico publicado en 2009

WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

scientific article published on 31 January 2019

Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration

artículo científico publicado en 2015

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells.

artículo científico publicado en 2018

miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.

artículo científico publicado en 2015

p53-dependent downregulation of metastasis-associated laminin receptor

artículo científico publicado en 2002

Lista de obras de Elda Tagliabue

"Omics" and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas.

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

Activity and resistance of trastuzumab according to different clinical settings.

Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane

Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency

Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities.

Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu

Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN

Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

Breast cancer and microRNAs: therapeutic impact.

Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression

Co-regulation and Physical Association of the 67-kDa Monomeric Laminin Receptor and the α6β4 Integrin

Combined targeting of EGFR and HER2 against prostate cancer stem cells

Correspondence

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.

Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation

Diadenosines as FHIT-ness instructors

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.

ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics

EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.

ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2

Exploiting poly(I:C) to induce cancer cell apoptosis.

Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells

Expression of Bone Sialoprotein in Human Lung Cancer

Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death

Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.

Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

Extracellular matrix proteins as diagnostic markers of breast carcinoma

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells

FOXP3 expression and overall survival in breast cancer.

FOXP3 expression in tumor cells and implications for cancer progression.

Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells.

Folate in head and neck squamous cell cancer chemoprevention: purposely left out?

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

HER2 as a target for breast cancer therapy.

HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

Heregulin β1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein

Human Renal Antigen Defined by a Murine Monoclonal Antibody2

Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation

Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands

Infiltrating mast cell-mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype

Influence of Antibiotic Treatment on Breast Carcinoma Development in Proto-neu Transgenic Mice

Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/Neu transgenic mice

Influence of lignans depletion on murine mammary gland morphology.

Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness

Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.

Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties

Mexican <i>Ganoderma Lucidum</i> Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet

MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases

Molecular cytogenetic characterization of stem-like cancer cells isolated from established cell lines

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype.

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress

Nerve Growth Factor Cooperates with p185HER2in Activating Growth of Human Breast Carcinoma Cells

New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors.